Company news
Latest News & Events
Company News
26 January 2023
US $7 million multi-year enterprise engagements for subscription data services
Read
Join us at Fierce Pharma Week
Join us at Fierce Pharma Week to explore innovative diagnostic-driven therapy commercialization strategies. Engage with experts and discover how real-world data can enhance HCP engagement.
View DetailPress releases
Company News
14 February 2024
Diaceutics enters into strategic alliance with KPMG
Company News
26 January 2023
US $7 million multi-year enterprise engagements for subscription data services
Company News
06 April 2022
Diaceutics CEO, Peter Keeling named in The Business & Finance CEO 100 Index 2022
Company News
25 March 2022
Nick Roberts joins Diaceutics as Chief Financial Officer
Company News
14 December 2021
US$1m contract with leading life sciences company for data feed from the DXRX platform
Company News
09 December 2021
Diaceutics announces the launch of its real-time Test Signal service in the US
Company News
13 September 2021
DXRX platform contract win
Company News
Diaceutics win multiple contracts for Inherited Retinal Disease (IRD) in APAC, EU, and US markets
Company News
Capital Markets Day 2021 Presentation
Notice of Capital Markets Day
Transfer of Shares and Director PDMR Shareholding
Issue of Share Options/PDMR Shareholdings
COVID-19 Testing Data licensing agreement
Summary of non-regulatory news and coverage for Q4, 2020
Diaceutics is pleased to announce that the Group's revenue for year end is ahead of revised market expectations
Company News
Susanne Munksted named to PharmaVoice 100 list of most inspiring leaders for 2023
Stay ahead with the diaceutics newsletter
Diagnostic-driven therapies are reshaping commercialization. Get evidence-based content, expert perspectives, and practical intelligence delivered straight to your inbox, every two weeks.
Ready to do commercialization differently?
Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find themso more people get the right therapy sooner.